Cumberland Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Cumberland Pharmaceuticals Inc. Earnings Date And Information
Cumberland Pharmaceuticals Inc. last posted its earnings results on Tuesday, August 10th, 2021. The company reported $0.08131 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.15131. The company had revenue of 9.09 M for the quarter and had revenue of 39.55 M for the year. Cumberland Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -1.38. Cumberland Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.
Cumberland Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/08/2024 | Q3 2024 | -$0.11 | $9.09 M | $9.09 M | ||
| 08/09/2024 | Q2 2024 | -$0.08 | $9.85 M | $9.85 M | ||
| 05/10/2024 | Q1 2024 | -$0.14 | $8.50 M | |||
| 03/12/2024 | Q4 2023 | -$0.44 | $9.35 M | |||
| 11/13/2023 | Q3 2023 | -$0.07 | $10.09 M | |||
| 08/11/2023 | Q2 2023 | $0.06 | $10.89 M | |||
| 05/12/2023 | Q1 2023 | $0.01 | $9.22 M | |||
| 03/13/2023 | Q4 2022 | -$0.17 | $9.12 M | |||
| 11/14/2022 | Q3 2022 | -$0.03 | $11.41 M | |||
| 08/12/2022 | Q2 2022 | -$0.09 | $10.30 M | |||
| 05/13/2022 | Q1 2022 | -$0.10 | $11.18 M | |||
| 03/11/2022 | Q4 2021 | -$0.26 | $8.32 M | |||
| 11/12/2021 | Q3 2021 | -$0.07 | $9.19 M | $8.07 M | ||
| 08/13/2021 | Q2 2021 | $0.08 | $8.57 M | $9.06 M | ||
| 05/14/2021 | Q1 2021 | $0.01 | $10.54 M | |||
| 03/12/2021 | Q4 2020 | -$0.06 | $10.26 M | |||
| 11/13/2020 | Q3 2020 | -$0.03 | $8.61 M | $9.25 M | ||
| 08/14/2020 | Q2 2020 | -$0.06 | $9.27 M | $9.60 M | ||
| 05/22/2020 | Q1 2020 | -$0.07 | $8.33 M | |||
| 03/20/2020 | Q4 2019 | -$0.06 | $13.68 M |
Cumberland Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Cumberland Pharmaceuticals Inc.'s earnings date?
Cumberland Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.
-
Did Cumberland Pharmaceuticals Inc. beat their earnings estimates last quarter?
In the previous quarter, Cumberland Pharmaceuticals Inc. (:CPIX) reported $0.08131 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.15131.
-
How can I listen to Cumberland Pharmaceuticals Inc.'s earnings conference call?
The conference call for Cumberland Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Cumberland Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Cumberland Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does Cumberland Pharmaceuticals Inc. generate each year?
Cumberland Pharmaceuticals Inc. (:CPIX) has a recorded annual revenue of $39.55 M.
-
How much profit does Cumberland Pharmaceuticals Inc. generate each year?
Cumberland Pharmaceuticals Inc. (:CPIX) has a recorded net income of $39.55 M. Cumberland Pharmaceuticals Inc. has generated $-0.44 earnings per share over the last four quarters.
-
What is Cumberland Pharmaceuticals Inc.'s price-to-earnings ratio?
Cumberland Pharmaceuticals Inc. (:CPIX) has a price-to-earnings ratio of -1.38 and price/earnings-to-growth ratio is 0.25.
